ELOXX PHARMACEUTICALS, INC. Notes Payable, Current
ELOXX PHARMACEUTICALS, INC. (ELOX) had Notes Payable, Current of $712.34 thousand as of 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:NotesPayableCurrent · last filed 2017-11-14
- 2017-09-30: Notes Payable, Current $712.34K.
- 2017-06-30: Notes Payable, Current $407.12K.
- 2017-03-31: Notes Payable, Current $256.82K.
- 2016-12-31: Notes Payable, Current $300.00K.
| Period end | Notes Payable, Current |
|---|---|
| 2017-09-30 | $712.34K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $407.12K 10-Q · filed 2017-11-14 |
| 2017-03-31 | $256.82K 10-Q · filed 2017-05-22 |
| 2016-12-31 | $300.00K 10-Q · filed 2017-02-10 |
| 2016-06-30 | $0.00 10-K · filed 2017-10-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |